Stock listing
ARTV Stock Price, News, Filings & Events — Artiva Biotherapeutics, Inc.
Selected listing: ARTV · NASDAQ · USD · US
This page tracks Artiva Biotherapeutics, Inc.'s ARTV:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ARTV:NASDAQ. ARTV:NASDAQ is the stock-level entry point for investors researching Artiva Biotherapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Artiva Biotherapeutics, Inc. (ticker: ARTV) is a public company operating in the American market, focusing on innovative biotherapeutic solutions. With a market capitalization of approximately $487.34 million, Artiva is dedicated to advancing its research and development efforts in the biotechnology sector. The company aims to address unmet medical needs through its cutting-edge therapies.

- Ticker
- ARTV:NASDAQ
- Asset type
- Stock
- Market cap
- $499.7M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Other
- Exchange
- NASDAQ
- Currency
- USD
Artiva Biotherapeutics, Inc. ARTV:NASDAQ stock context
This page tracks Artiva Biotherapeutics, Inc.'s ARTV:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ARTV:NASDAQ. ARTV:NASDAQ is the stock-level entry point for investors researching Artiva Biotherapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Artiva Biotherapeutics, Inc. (ticker: ARTV) is a public company operating in the American market, focusing on innovative biotherapeutic solutions. With a market capitalization of approximately $487.34 million, Artiva is dedicated to advancing its research and development efforts in the biotechnology sector. The company aims to address unmet medical needs through its cutting-edge therapies.
Latest news from Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics to Participate in Upcoming Investor Conferences in September
September 2, 2026
Artiva Biotherapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights
August 6, 2026
Artiva Biotherapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 17, 2026
Artiva Biotherapeutics to Participate in the H.C. Wainwright 4th Annual Cell Therapy Virtual Conference
June 23, 2026
Artiva Biotherapeutics Highlights AlloNK® Data Presented at EULAR 2026, FDA RMAT Designation in Refractory Rheumatoid Arthritis and Webca...
June 8, 2026
Research Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics, Inc. investor report
Review AI stock analysis and investor report context for ARTV:NASDAQ.
Artiva Biotherapeutics, Inc. company profile
View the public company page for Artiva Biotherapeutics, Inc. on 6ix.
Artiva Biotherapeutics, Inc. news
Read company news and market updates connected to Artiva Biotherapeutics, Inc..
Artiva Biotherapeutics, Inc. investor events
Find investor webinars, events, and replay context for Artiva Biotherapeutics, Inc..